Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Chronic Obstructive Pulmonary Disease Patient Preferences Survey

1 décembre 2020 mis à jour par: Dennis Jensen, Ph.D., McGill University

COPD Patient Preferences, Activities, and Participation Survey

The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.

Aperçu de l'étude

Statut

Complété

Intervention / Traitement

Type d'étude

Observationnel

Inscription (Réel)

200

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Quebec
      • Montreal, Quebec, Canada, H4A 3J1
        • Montreal Chest Institute of the McGill University Health Center (MUHC)

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

40 ans à 90 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Adults living with chronic obstructive pulmonary disease (COPD).

La description

Inclusion Criteria:

  • Clinical diagnosis of COPD
  • English or French speaking
  • Patient at one of the three participating sites with medical chart

Exclusion Criteria:

  • No diagnosis of COPD by a healthcare professional
  • Unable to communicate in English or French
  • Unable to provide informed consent
  • No medical chart information at one of the three participating sites

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Quartile 1 [Mild]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 2 [Moderate]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 3 [Severe]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 4 [Very Severe]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Number of Participants Who Prioritized Healthcare Topics
Délai: Baseline
Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups. Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups. Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time. For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time). The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Prioritized Research Topics
Délai: Baseline
Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014). The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic. A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women). Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics. Participants could assign anywhere between 10% of funding to 100% of funding to the topics. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities
Délai: Baseline

Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below.

Activity 1: Walking from one place to another outside of your home on a flat surface.

Activity 2: Moving from one place to another using motorized transportation.

Activity 3: Climbing two or more flights of stairs.

Activity 4: Walking up a hill.

Activity 5: Participating in regular exercise.

Activity 6: Walking from one place to another in your home.

Activity 7: Carrying light objects on a flat surface.

Activity 8: Carrying heavy objects on a flat surface.

Activity 9: Carrying-out low intensity physical activities

Baseline

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Forced Expiratory Volume in 1-sec (FEV1)
Délai: Baseline
Individuals forced expiratory volume in 1-sec (FEV1) as assessed by spirometry
Baseline
FEV1/FVC
Délai: Baseline
Individuals FEV1-to-forced vital capacity (FVC) ratio
Baseline
Modified Medical Research Council Questionnaire on Breathlessness
Délai: Baseline
Self-reported intensity of activity related breathlessness as assessed by the modified Medical Research Council (mMRC) dyspnea scale (0-4). This questionnaire was used to measure participants' breathlessness burden using a single item scale from 0 to 4, where a score of 0-1 indicated mild breathlessness and 2-4 indicated increased breathlessness.
Baseline
COPD Assessment Test
Délai: Baseline
This questionnaire measure the impact COPD is having on well being and daily life. The CAT is an eight-item semantic differential scale from 0 to 5, where 0 is no impact and 5 is extremely impactful. Items include: I never cough| I cough all the time, I have no phlegm (mucus) in my chest at all | My chest is completely full of phlegm (mucus), My chest does not feel tight at all | My chest feels very tight, When I walk up a hill or one flight of stairs, I am not breathless | When I walk up a hill or one flight of stairs, I am very breathless, I am not limited doing any activities at home| I am very limited doing activities at home, I am confident leaving my home despite my lung condition| I am not at all confident leaving my home because of my lung condition, I sleep soundly | I don't sleep soundly because of my lung condition, I have lots of energy I have no energy at all. Participants' scores were totaled and a score of ≥ 10 indicated higher than normal burden of disease.
Baseline
Godin Leisure Time Physical Activity Questionnaire
Délai: Baseline
Self-reported physical activity levels measured in length of bouts over the previous 7 days to determine physical activity frequency.
Baseline
Satisfaction of Life Questionnaire
Délai: Baseline
This 5 item questionnaire was used to measure participants' level of life satisfaction. The higher the score, the higher the sense of life satisfaction. A score from 5-9 indicated extremely dissatisfied, 10-14 is dissatisfied, 15-19 indicated slightly below average life satisfaction. 20-24 is the average score, 25-29 is a high score indicative of higher life satisfaction and a score between 30-35 is a very high score and represent very high life satisfaction.
Baseline
Number of Participants With Exacerbations Due to COPD in the Preceding 12 Months
Délai: baseline
An exacerbation was defined as a change in medication due to a COPD exacerbation (i.e., the prescription of prednisone or a medical action plan) as indicated in the medical chart or hospital admission due to a COPD exacerbation.
baseline

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Collaborateurs

Les enquêteurs

  • Chercheur principal: Shane N Sweet, Ph.D., McGill University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 novembre 2016

Achèvement primaire (Réel)

1 octobre 2017

Achèvement de l'étude (Réel)

12 décembre 2018

Dates d'inscription aux études

Première soumission

26 avril 2016

Première soumission répondant aux critères de contrôle qualité

18 novembre 2016

Première publication (Estimation)

22 novembre 2016

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

24 décembre 2020

Dernière mise à jour soumise répondant aux critères de contrôle qualité

1 décembre 2020

Dernière vérification

1 décembre 2020

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 15-203-MUHC

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Patient Survey

3
S'abonner